Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism.
Archives of General Psychiatry October 1, 1968 DOI: 10.1001/archpsyc.1968.01740100124021 via OpenAlex
Summary
AI-generated from the abstractThe history of LSD in medicine follows a typical pattern: initial speculation, exaggerated claims, and then controlled trials. This book is the first report on the latter category. LSD would be just another psychoactive drug if not for two factors: its adoption by young drug users for psychedelic effects, which has generated enormous publicity, and the fact that a drug producing profound mental changes in tiny doses (less than 50 micrograms) likely touches the core of some vital neurological process.
Study at a glance
| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Dose | under 50μg |
| Topics | LSD |
| Keywords | Publicity Speculation Psychology Psychiatry |
| Citations | 9 |
| Key finding | LSD's adoption by young drug users for psychedelic effects and its ability to produce profound mental changes in tiny doses (less than 50 micrograms) set it apart from other psychoactive drugs. |
Abstract
The history of the use of LSD in medicine follows the usual pattern for a new drug: first, speculation on its use and mechanisms following preliminary browsing research; second, exaggerated claims about its value; and third, carefully controlled trials. This book is the first in what will undoubtedly be a long list of reports on the latter category. It is important for its virtues as well as for its deficiencies. LSD would be just another in the list of psychoactive drugs which show promise of usefulness if it were not for two factors. The first is that it has been taken up by young drug users for its "psychedelic" effects and has received enormous popular publicity. The second is that one cannot help being convinced that a drug which can produce such profound mental changes in such tiny doses (<50μg) is probably touching the core of some vital neurological process